BioCentury
ARTICLE | Financial News

Genzyme raises Renagel guidance

May 4, 2001 7:00 AM UTC

GENZ raised its 2001 revenue guidance for Renagel sevelamer non-absorbed phophate binder to $130-$140 million from $120-$130 million based on continued strong performance of the product in the U.S. an...